Longevity & Biohacking
Cardiac Stress Test Accuracy: Gaps Watchdogs Must See
New research exposes cardiac stress test accuracy failures between local sites and core labs. Here's what patients and watchdogs need to know.
Beat
Longevity & Biohacking
Longevity and biohacking through an access lens: what is available online, what the evidence says, and which providers are credible.
Longevity & Biohacking
COPD Digital Tools: Gaps Watchdogs Must See
New research exposes where COPD digital tools fall short for rural and underserved patients—and what watchdogs, clinicians, and policymakers must do next.
Longevity & Biohacking
Chronic Disease Telehealth: Gaps Watchdogs Must Close
Chronic disease telehealth shows real promise but critical gaps in literacy, access, and oversight threaten longevity outcomes. Here's what the data reveal.
Longevity & Biohacking
Telehealth Gaps in Chronic Disease Care
Telehealth gaps in chronic disease care threaten longevity. New research exposes barriers in COPD, diabetes, heart failure, and more. Read the watchdog report.
Longevity & Biohacking
Telehealth Literacy Gaps Threaten Longevity
Telehealth literacy gaps put rural and aging patients at risk. New research reveals what providers and policymakers must fix now.
Longevity & Biohacking
Telehealth Gaps in Rural Longevity Care
Telehealth promises longer, healthier lives—but rural and underserved populations still face critical access gaps. A watchdog look at the evidence.
Longevity & Biohacking
The online longevity boom: what you're actually buying
Telehealth longevity clinics sell tests, peptides, and off-label prescriptions with the promise of more years. Here's how to read the menu with a clear head.
Longevity & Biohacking
Biological-age tests sold online: what you're actually buying
Epigenetic clocks and biomarker panels ship to your door for $200-$600. Here's who runs the labs, what the evidence supports, and how to read the marketing.